Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Is Medical Education a Public or a Private Good?

Is Medical Education a Public or a Private Good? Editorial Opinion http://www.ema.europa.eu/docs/en_GB 10. Lan KKG, DeMets DL. Discrete sequential with betrixaban in acutely ill medical patients. /document_library/Scientific_guideline boundaries for clinical trials. Biometrika. 1983;70 N Engl J Med. 2016;375(6):534-544. /2010/09/WC500096793.pdf. Published July 1, (3):659-663. 14. Baron JA, Sandler RS, Bresalier RS, et al. 2010. Accessed November 5, 2017. 11. Echt DS, Liebson PR, Mitchell LB, et al; Cardiovascular events associated with rofecoxib: 7. National Research Council. The Prevention and CAST Investigators. Mortality and morbidity in final analysis of the APPROVe trial. Lancet. 2008; Treatment of Missing Data in Clinical Trials. patients receiving encainide, flecainide, 372(9651):1756-1764. Washington, DC: The National Academies Press; or placebo: the Cardiac Arrhythmia Suppression 15. Wedel H, Demets D, Deedwania P, et al; 2010. Trial. N Engl J Med. 1991;324(12):781-788. MERIT-HF Study Group. Challenges of subgroup 8. Gamble C, Krishan A, Stocken D, et al. Guidelines 12. Taylor AL, Ziesche S, Yancy C, et al; analyses in multinational clinical trials: for the content of statistical analysis plans in clinical African-American Heart Failure Trial Investigators. experiences from the Merit-HF Trial. Am Heart J. trials. JAMA. doi:10.1001/jama.2017.18556 Combination of isosorbide dinitrate and hydralazine 2001;142(3):502-511. in blacks with heart failure. N Engl J Med. 2004;351 9. DeMets DL, Ellenberg http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Is Medical Education a Public or a Private Good?

JAMA , Volume 318 (23) – Dec 19, 2017

Loading next page...
 
/lp/american-medical-association/is-medical-education-a-public-or-a-private-good-t3ruSEGd2E
Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2017.17552
pmid
29260204
Publisher site
See Article on Publisher Site

Abstract

Editorial Opinion http://www.ema.europa.eu/docs/en_GB 10. Lan KKG, DeMets DL. Discrete sequential with betrixaban in acutely ill medical patients. /document_library/Scientific_guideline boundaries for clinical trials. Biometrika. 1983;70 N Engl J Med. 2016;375(6):534-544. /2010/09/WC500096793.pdf. Published July 1, (3):659-663. 14. Baron JA, Sandler RS, Bresalier RS, et al. 2010. Accessed November 5, 2017. 11. Echt DS, Liebson PR, Mitchell LB, et al; Cardiovascular events associated with rofecoxib: 7. National Research Council. The Prevention and CAST Investigators. Mortality and morbidity in final analysis of the APPROVe trial. Lancet. 2008; Treatment of Missing Data in Clinical Trials. patients receiving encainide, flecainide, 372(9651):1756-1764. Washington, DC: The National Academies Press; or placebo: the Cardiac Arrhythmia Suppression 15. Wedel H, Demets D, Deedwania P, et al; 2010. Trial. N Engl J Med. 1991;324(12):781-788. MERIT-HF Study Group. Challenges of subgroup 8. Gamble C, Krishan A, Stocken D, et al. Guidelines 12. Taylor AL, Ziesche S, Yancy C, et al; analyses in multinational clinical trials: for the content of statistical analysis plans in clinical African-American Heart Failure Trial Investigators. experiences from the Merit-HF Trial. Am Heart J. trials. JAMA. doi:10.1001/jama.2017.18556 Combination of isosorbide dinitrate and hydralazine 2001;142(3):502-511. in blacks with heart failure. N Engl J Med. 2004;351 9. DeMets DL, Ellenberg

Journal

JAMAAmerican Medical Association

Published: Dec 19, 2017

References